02/06
Headlines

NASDAQ:CPRX

Top News: Eclipse Resources Corporation (NYSE:ECR), Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), General Motors Company (NYSE:GM), TransDigm Group Incorporated (NYSE:TDG), Meru Networks (NASDAQ:MERU)

Kevin Long03 mins

On Dec 29, Eclipse Resources Corporation (NYSE:ECR) announced that the Company has entered into an agreement to sell 62,500,000 shares of common stock for $440 million in a private placement transaction, which is expected to result in net proceeds to the Company of approximately $434 million (after deducting placement agent commissions and the Company’s estimated…

Read More

Eye Catching Stocks : Alcatel Lucent SA (ADR) (NYSE:ALU), Citigroup Inc. (NYSE:C), Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), Lightbridge Corp. (NASDAQ:LTBR), Ford Motor Company (NYSE:F)

Colin Pettis02 mins

Accenture and Alcatel Lucent SA (ADR) (NYSE:ALU) have formed a strategic alliance to help communications service providers (CSPs) and large enterprises implement integrated ultra-broadband solutions to address the challenges of rising costs and increased data consumption caused by high demand from digital customers and applications. Alcatel Lucent SA (ADR) (NYSE:ALU) belongs to Technology sector. Its…

Read More

Today’s Watch List: Las Vegas Sands Corp. (NYSE:LVS), Superconductor Technologies Inc. (NASDAQ:SCON), PZG, Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Blount International (NYSE:BLT)

Jayne Crisman02 mins

Shareholders of Las Vegas Sands Corp (NYSE: LVS) looking to boost their income beyond the stock’s 3.2% annualized dividend yield can sell the January 2016 covered call at the $77.50 strike and collect the premium based on the $2.37 bid, which annualizes to an additional 2.8% rate of return against the current stock price (at…

Read More

Micro-cap Volatile Stocks: Catalyst Pharmaceutical Partners (NASDAQ:CPRX), MeetMe (NASDAQ:MEET), ParkerVision (NASDAQ:PRKR), PowerSecure International, Inc. (NYSE:POWR), China Recycling Energy Corp. (NASDAQ:CREG)

Jayne Crisman03 mins

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) announced that the Company is set to join the Russell Microcap Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes. Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) stock performance was 0.82% in…

Read More

Watch List: Neurocrine Biosciences (NASDAQ:NBIX), Karyopharm Therapeutics Inc (NASDAQ:KPTI), Catalyst Pharmaceutical (NASDAQ:CPRX), Supernus Pharmaceuticals Inc (NASDAQ:SUPN), The Medicines Company (NASDAQ:MDCO)

Colin Pettis03 mins

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) announced that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Jefferies 2014 Global Healthcare Conference in New York City. Neurocrine Biosciences, Inc. (NASDAQ:NBIX) stock performance was 0.22% in last session and finished the day at $13.94. Traded volume was million shares in the last…

Read More

Stocks to Watch: Horizon Pharma Inc (NASDAQ:HZNP), Avanir Pharmaceuticals (NASDAQ:AVNR), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Supernus Pharmaceuticals (NASDAQ:SUPN)

Chris Lewis02 mins

Specialist pharmaceutical company Horizon Pharma Inc (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled “Delayed-Release Tablet with Defined Core Geometry” that covers its US approved product RAYOS. Horizon Pharma Inc (NASDAQ:HZNP) stock performance was -7.89% in last session and finished the day at $12.02. Traded volume was…

Read More